Scientists Uncover Why Colorectal Cancer Evades Immune Defense

Scientists have discovered that in colorectal cancer, two subtypes of regulatory T cells play opposing roles, with one subtype helping to restrain tumor growth and the other promoting it. This finding could lead to more targeted immunotherapies that selectively eliminate harmful Tregs, improving outcomes for patients.